Scholarlink

<p>Parkinson’s disease (PD) is the main neurodegenerative disorder affecting motor activity, there are different pathophysiological pathways contributing to its development including oxidative stress, neuroinflammation, Lewy’s bodies accumulation, and impaired autophagy. Vinpocetine is an herbal extract with antioxidant and anti-inflammatory activities that may counteract pathophysiologic neurodegeneration pathways. Moreover, <i>Lactobacillus</i> is a probiotic that can modulate the gut-brain axis and provide the body with the needed precursors of antioxidants and anti-inflammatory mediators. In the current study PD was induced experimentally in Sprague Dawley rats with rotenone (2.5&#xa0;mg/kg, i.p, daily) for 60 days, vinpocetine; Vinpo (20&#xa0;mg/kg, orally, daily) and <i>Lactobacillus; Lacto</i> (2.7 × 10<sup>8</sup> CFU/ml, orally, daily) were applied as protective treatment. Vinpocetine and <i>Lactobacillus</i> treatment significantly ameliorated motor function by increasing distance traveled and rearing frequency in the open field test with a concomitant increase in falling time from both the accelerating rotarod and the wire screen test. Moreover, vinpocetine and <i>Lactobacillus</i> treatment upregulates tyrosine hydroxylase expression (the rate-limiting enzyme in dopamine synthesis), leading to enhanced dopamine synthesis and improved dopaminergic function with regression of histopathological hallmarks. Antioxidant GSH levels were significantly increased after vinpocetine and <i>Lactobacillus</i> treatment with a significant decrease in MDA content in brain homogenates. Furthermore, vinpocetine and <i>Lactobacillus</i> treatment significantly decreased striatal inflammatory markers; nitrite, IL-1β and TNF-α. Proteinopathies were regressed with a substantial decrease in striatal α-synuclein and tau content. In conclusion, vinpocetine and <i>Lactobacillus</i> treatment reduced rotenone neurotoxicity with improved dopamine release and motor activity with correction of oxidative burden, neuro-inflammation, and proteinopathy.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Vinpocetine and Lactobacillus Attenuated Rotenone-Induced Parkinson’s Disease and Restored Dopamine Synthesis in Rats through Modulation of Oxidative Stress, Neuroinflammation, and Lewy Bodies Inclusion

  • 期刊论文

  • 发表日期：

    2025年2月15日

查看全文
  • Hanan M. Hassan,
  • Hadeer O. Abou-Hany,
  • Ahmed Shata,
  • Doaa Hellal,
  • Ahmed M. El-Baz,
  • Zeinab H. ElSaid,
  • Amira A. Haleem,
  • Nesreen Elsayed Morsy,
  • Rawan M. Abozied,
  • Bassant M. Elbrolosy,
  • Sally Negm,
  • Attalla F. El-kott,
  • Mohammed A. AlShehri,
  • Mohamad A. Khasawneh,
  • Eman R Saifeldeen,
  • Marwa M. Mahfouz

摘要

Parkinson’s disease (PD) is the main neurodegenerative disorder affecting motor activity, there are different pathophysiological pathways contributing to its development including oxidative stress, neuroinflammation, Lewy’s bodies accumulation, and impaired autophagy. Vinpocetine is an herbal extract with antioxidant and anti-inflammatory activities that may counteract pathophysiologic neurodegeneration pathways. Moreover, Lactobacillus is a probiotic that can modulate the gut-brain axis and provide the body with the needed precursors of antioxidants and anti-inflammatory mediators. In the current study PD was induced experimentally in Sprague Dawley rats with rotenone (2.5 mg/kg, i.p, daily) for 60 days, vinpocetine; Vinpo (20 mg/kg, orally, daily) and Lactobacillus; Lacto (2.7 × 108 CFU/ml, orally, daily) were applied as protective treatment. Vinpocetine and Lactobacillus treatment significantly ameliorated motor function by increasing distance traveled and rearing frequency in the open field test with a concomitant increase in falling time from both the accelerating rotarod and the wire screen test. Moreover, vinpocetine and Lactobacillus treatment upregulates tyrosine hydroxylase expression (the rate-limiting enzyme in dopamine synthesis), leading to enhanced dopamine synthesis and improved dopaminergic function with regression of histopathological hallmarks. Antioxidant GSH levels were significantly increased after vinpocetine and Lactobacillus treatment with a significant decrease in MDA content in brain homogenates. Furthermore, vinpocetine and Lactobacillus treatment significantly decreased striatal inflammatory markers; nitrite, IL-1β and TNF-α. Proteinopathies were regressed with a substantial decrease in striatal α-synuclein and tau content. In conclusion, vinpocetine and Lactobacillus treatment reduced rotenone neurotoxicity with improved dopamine release and motor activity with correction of oxidative burden, neuro-inflammation, and proteinopathy.

Graphical Abstract